Hydrocortisone-17-butyrate - CAS 13609-67-1
Catalog number: 13609-67-1
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H36O6
Molecular Weight:
432.55
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Hydrocortisone-17-butyrate, a glucocorticoid compound, could be used as antiinflammatory and immunosuppresive agent.
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
Powder
Synonyms:
11b,17,21-trihydroxypregn-4-ene-3,20-dione 17-butyrate;11BETA,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE 17-BUTYRATE;HYDROCORTISONE 17-BUTYRATE;HYDROCORTISONE BUTYRATE;CORTISOL 17-BUTYRATE;11-beta,17-alpha,21-trihydroxy-4-pregnene-3,20-dione17-alpha-butyrate
Solubility:
10 mM in DMSO
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
Hydrocortisone-17-butyrate could be used as antiinflammatory and immunosuppresive agent.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
585.6ºC at 760mmHg
Density:
1.23g/cm3
InChIKey:
BMCQMVFGOVHVNG-TUFAYURCSA-N
InChI:
InChI=1S/C25H36O6/c1-4-5-21(30)31-25(20(29)14-26)11-9-18-17-7-6-15-12-16(27)8-10-23(15,2)22(17)19(28)13-24(18,25)3/h12,17-19,22,26,28H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1
Canonical SMILES:
CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
1.Allergic contact dermatitis caused by prednicarbate presenting as chronic hand eczema.
Otero-Rivas MM1, Ruiz-González I1, Pérez-Bustillo A1, Rodríguez-Prieto MÁ1. Contact Dermatitis. 2015 Jul;73(1):51-2. doi: 10.1111/cod.12374. Epub 2015 Apr 13.
2.Non steroid treatment for eczema: results from a controlled and randomized study.
De Waure C1, Cadeddu C, Venditti A, Barcella A, Bigardi A, Masci S, Virno G, Cammisa A, Ricciardi W. G Ital Dermatol Venereol. 2013 Oct;148(5):471-7.
AIM: This study assesses the efficacy of a new non steroid anti-inflammatory product in comparison to Hydrocortisone Butyrate 0.1% Cream in healing eczematous dermatitis.
3.Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.
Yang X1, Patel S, Sheng Y, Pal D, Mitra AK. AAPS PharmSciTech. 2014 Jun;15(3):569-87. doi: 10.1208/s12249-014-0072-4. Epub 2014 Feb 7.
The aim of this investigation was to develop hydrocortisone butyrate (HB)-loaded poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NP) with ideal encapsulation efficiency (EE), particle size, and drug loading (DL) under emulsion solvent evaporation technique utilizing various experimental statistical design modules. Experimental designs were used to investigate specific effects of independent variables during preparation of HB-loaded PLGA NP and corresponding responses in optimizing the formulation. Plackett-Burman design for independent variables was first conducted to prescreen various formulation and process variables during the development of NP. Selected primary variables were further optimized by central composite design. This process leads to an optimum formulation with desired EE, particle size, and DL. Contour plots and response surface curves display visual diagrammatic relationships between the experimental responses and input variables.
4.Allergic contact dermatitis induced by topical hydrocortisone-17-butyrate mimicking papular rosacea.
D'Erme AM, Gola M. Dermatitis. 2012 Mar-Apr;23(2):95-6. doi: 10.1097/DER.0b013e31824a609f.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 72795-01-8 ICI 118551 hydrochloride

ICI 118551 hydrochloride
(CAS: 72795-01-8)

ICI 118551 hydrochloride is a highly selective β2 adrenergic antagonist (Ki values are 1.2, 120 and 257 nM for β2, β1 and β3 receptors respectively), inhibited ...

VIBEGRON
(CAS: 1190389-15-1)

This active molecular is a selective Beta 3 Adrenergic Receptor Agonist and was developed by Kyorin Pharmaceutical for the treatment of OAB (Overactive Bladder)...

CAS 318-98-9 Propranolol Hydrochloride

Propranolol Hydrochloride
(CAS: 318-98-9)

Propranolol hydrochloride, with antihypertensive, antianginal and antiarrhythmic (class II) properties, is a non-cardioselective adrenergic-beta antagonist and ...

CAS 63590-64-7 Terazosin

Terazosin
(CAS: 63590-64-7)

Terazosin, works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls, is a selective alpha1-antagonist used for trea...

CAS 158599-53-2 Zoleprodolol

Zoleprodolol
(CAS: 158599-53-2)

Zoleprodolol, an oxadiazol derivative, has been found to be an adrenergic receptor antagonist.

CAS 149247-12-1 QF0301B

QF0301B
(CAS: 149247-12-1)

QF0301B is an α1 adrenergic receptor antagonist and shows noncompetitive low action in 5-HT3, muscarinic and nicotinic receptors, or as Ca2+ antagonist.

MK-761
(CAS: 65321-41-7)

MK-761 has beta adrenoceptor antagonist and vasodilating properties in a single molecule. It has beta adrenoceptor blocking activity in the isolated cat heart p...

CAS 148408-65-5 Sunepitron hydrochloride

Sunepitron hydrochloride
(CAS: 148408-65-5)

Sunepitron hydrochloride is a potent and selective serotonin 5-HT1A autoreceptor agonist, α2-adrenergic antagonist, and dopamine D2 agonist. The phase III clini...

CAS 65-28-1 Phentolamine Mesylate

Phentolamine Mesylate
(CAS: 65-28-1)

Phentolamine Mesylate is a nonselective alpha-adrenergic antagonist with IC50 of 0.1 μM.

CAS 54-80-8 Pronetalol

Pronetalol
(CAS: 54-80-8)

Pronethalol is a non-selective beta-adrenergic blocking agentused in treatment due to carcinogenic properties.

CAS 56-47-3 Deoxycorticosterone acetate

Deoxycorticosterone acetate
(CAS: 56-47-3)

Deoxycorticosterone acetate is a steroid hormone used for intramuscular injection for replacement therapy of the adrenocortical steroid.

CAS 70024-40-7 Terazosin HCl

Terazosin HCl
(CAS: 70024-40-7)

Terazosin is a selective alpha 1 antagonist used for treatment of symptoms of an enlarged prostate (BPH).

CAS 133163-28-7 Midodrine

Midodrine
(CAS: 133163-28-7)

Midodrine is a Alpha adrenergic receptor under the development of Shire for the treatment of dysautonomia and orthostatic hypotension. In August 2010, the FDA p...

CAS 106133-20-4 Tamsulosin

Tamsulosin
(CAS: 106133-20-4)

Tamsulosin could block on the sympathetic α1 receptor, especially selectively bind to the α1A receptor and has been found to be effective in the treatment of be...

CAS 98418-47-4 Metoprolol succinate

Metoprolol succinate
(CAS: 98418-47-4)

Metoprolol succinate is a selective β-adrenoceptor antagonist. It is used in treatment of several diseases of the cardiovascular system. It is a drug used in th...

CAS 5704-60-9 Nifenalol HCl

Nifenalol HCl
(CAS: 5704-60-9)

Nifenalol, also known as INPEA, is a novel antagonist of β-adrenoceptors.

CAS 116209-55-3 Levobetaxolol HCl

Levobetaxolol HCl
(CAS: 116209-55-3)

Levobetaxolol exhibits a higher affinity at cloned human β1 and β2 receptors with Ki value of 0.76 nM and 32.6 nM, respectively.

CAS 7683-59-2 isoproterenol

isoproterenol
(CAS: 7683-59-2)

Isoproterenol can be used for the treatment of bradycardia (slow heart rate), heart block, and rarely for asthma. It is a non-selective β adrenoreceptor agonist...

CHIR 2279
(CAS: 158198-45-9)

CHIR 2279, an isoquinolin derivative, was once studied against hypertension as an α1 adrenergic receptor antagonist.

SNAP-8719 HCl
(CAS: 255893-38-0)

SNAP-8719, structurally very similar to BMY-7378, is a selective, orally active α1D-AR antagonist with lower binding affinity for the 5-HT1A receptor.

Chemical Structure

CAS 13609-67-1 Hydrocortisone-17-butyrate

Quick Inquiry

Verification code

Featured Items